☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
vertex
PharmaShots Weekly Snapshots (April 08 – April 12, 2024)
April 12, 2024
Vertex to Acquire Alpine Immune Sciences for ~$4.9B
April 11, 2024
Vertex Receives CHMP’s Positive Opinion for Kalydeco as a Treatment of Cystic Fibrosis in Infants
February 23, 2024
Insights+: EMA Marketing Authorization of New Drugs in November 2023
December 29, 2023
Vertex’s Kaftrio+Ivacafor Receives EC’s Approval for the Treatment of Children aged 2 to 5yrs. with Cystic Fibrosis (CF)
November 24, 2023
Vertex and CRISPR Therapeutics Received MHRA’s Authorization for Casgevy to Treat Sickle Cell Disease and Transfusion-Dependent Be...
November 16, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.